Fábio Jorge Ramalho de Amorim

Fábio Jorge Ramalho de Amorim

Auto-generated profile, based on publicly available information

Fábio Jorge Ramalho de Amorim

Laboratory of Teaching and Research in Social Pharmacy (LEPFS), Health Sciences Graduate Program, Federal University of Sergipe, São Cristóvão, SE, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2025 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
GAGiulyane Targino Aires-Moreno
Giulyane Targino Aires-Moreno
LMLaís Garcia Marques
Laís Garcia Marques
SRSheila Feitosa Ramos
Sheila Feitosa Ramos
FAFernando de Castro Araújo-Neto
Fernando de Castro Araújo-Neto
RSRafaella de Oliveira Santos Silva
Rafaella de Oliveira Santos Silva
DLDivaldo Lyra
Divaldo Lyra

21 April 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
FAFábio Jorge Ramalho de Amorim
Fábio Jorge Ramalho de Amorim
FVFernanda Valença-Feitosa
Fernanda Valença-Feitosa
MRMarcos Cardoso Rios
Marcos Cardoso Rios
CSCarlos Adriano Santos Souza
Carlos Adriano Santos Souza
IBIzadora Menezes da Cunha Barros
Izadora Menezes da Cunha Barros
DLDivaldo Pereira de Lyra-Júnior
Divaldo Pereira de Lyra-Júnior
Background: The clinical activities developed by pharmacists in a hospital environment can improve health outcomes and generate savings for hospitals. However, to determine whether pharmaceutical interventions are cost effective, it is essential to define a method according to which cost-effectiveness is intended to be measured. In addition, the quality of economic assessments and the amount of information present in systematic reviews in the literature make it difficult to analyze the effects of this intervention. Objective: This paper aims to provide an overview of systematic reviews on the pharmacoeconomic impact of the performance of pharmaceutical care in hospitals. Methods: A systematic search of the Cochrane Library databases, PubMed or MEDLINE, LILACS, Scopus, Web of Science, Google Scholar, and Open Thesis will be performed using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The search will involve the use of keywords determined using the Medical Subject Headings database to define the search terms and include the following terms: “pharmacoeconomics,” “pharmaceutical care,” and “hospital.” The study designs to be included will be systematic reviews of good quality. Studies will be included that address pharmacoeconomics; studies that evaluated pharmaceutical care in hospitals; and studies published in Portuguese, English, or Spanish. The primary outcome sought in the systematic reviews will be the cost ratio in monetary units and the outcomes in monetary or natural units. The secondary economic outcomes considered will be determined based on factors associated with the drugs and translated into benefit, efficacy, or utility. Results: It is intended to start this overview in January 2023. Thus far, only previous searches have been carried out to contextualize the theme and build the protocol. Conclusions: This overview will determine the pharmacoeconomic impact of pharmaceutical care interventions in the hospital environment. In addition, this study will point out which clinical outcomes in natural units are impacted by the performance of pharmaceutical care and the strengths and limitations of each approach. It will also identify gaps in the literature and areas for future work. Trial Registration: PROSPERO CRD42019140665; https://tinyurl.com/bddwnz43

3 May 2022 in Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
Verified
Journal Article
Open access
PDF file
BSBianca L. Santos
Bianca L. Santos
MBMaria L. Barros
Maria L. Barros
GOGessica U. Oliveira
Gessica U. Oliveira
DODaniela T. Oliveira
Daniela T. Oliveira
LALucimara M. Andrade
Lucimara M. Andrade
FAFábio J. Amorim
Fábio J. Amorim
Objetivo: Realizar a avaliação de prescrições de oxigenoterapia de pacientes sob cuidados clínicos internados em um hospital de ensino de Sergipe. Métodos: Trata-se de um estudo transversal, descritivo, retrospectivo e quantitativo, no qual foram avaliados os prontuários e prescrições de 28 pacientes em uso de oxigênio (O2) internados entre os meses de março a junho de 2021. Os pacientes foram avaliados quanto à indicação de O2 e saturação de oxigênio (SatO2) inicial, e as prescrições quanto à inclusão do O2 na prescrição, saturação alvo, dispositivo de entrega do O2 e fluxo inicial ou concentração de O2 inicial inspirada. Após a coleta dos dados foi formado um painel de especialistas composto por pneumologista, fisioterapeutas e farmacêuticas para avaliar os achados e sugerirem intervenções a serem realizadas. Resultados: Dos pacientes avaliados, 89,3% tinham indicação de oxigenoterapia, mas 72,4% dos prontuários não apresentavam informação sobre SatO2 inicial. Da amostra analisada, 53,6% não tinham O2 prescrito, 75,0% não apresentavam meta de SatO2, 42,9% não apresentavam o dispositivo de entrega de O2, e 67,9% não continham o fluxo inicial ou concentração inspirada de O2 inicial. Além disso, o cateter nasal foi o dispositivo mais prescrito (85,2%). O painel de especialistas sugeriu nove intervenções para serem realizadas, que envolveram desde a realização de treinamentos com os profissionais envolvidos em todo o processo de uso do oxigênio medicinal, até a modificação do modelo de prescrição médica atual para atender aos requisitos necessários para uma prescrição de oxigênio adequada, com o intuito de promover a prática do uso racional de oxigênio e adequações no processo de trabalho. Conclusão: O estudo demonstrou que a maioria dos itens avaliados nas prescrições de oxigênio apresentavam não-conformidades diante das recomendações internacionais. Estes achados justificam a realização de intervenções junto à equipe assistencial.

23 January 2025 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
TSTâmara Natasha Gonzaga de Andrade Santos
Tâmara Natasha Gonzaga de Andrade Santos
GMGivalda Mendonça da Cruz Macieira
Givalda Mendonça da Cruz Macieira
RSRafaella de Oliveira Santos Silva
Rafaella de Oliveira Santos Silva
GBGiselle de Carvalho Brito
Giselle de Carvalho Brito
SNSabrina Joany Felizardo Neves
Sabrina Joany Felizardo Neves
AOAlfredo Dias Oliveira-Filho
Alfredo Dias Oliveira-Filho

23 January 2025 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
TSTâmara Natasha Gonzaga de Andrade Santos
Tâmara Natasha Gonzaga de Andrade Santos
GMGivalda Mendonça da Cruz Macieira
Givalda Mendonça da Cruz Macieira
KRKérilin Stancine Santos Rocha
Kérilin Stancine Santos Rocha
MNMônica Thais Ferreira Nascimento
Mônica Thais Ferreira Nascimento
FNFernando de Castro Araújo Neto
Fernando de Castro Araújo Neto
AOAlfredo Dias Oliveira-Filho
Alfredo Dias Oliveira-Filho

20 December 2021 in JMIR Preprints
Verified
Preprint
Open access
FAFábio Jorge Ramalho de Amorim
Fábio Jorge Ramalho de Amorim
FVFernanda Valença-Feitosa
Fernanda Valença-Feitosa
MRMarcos Cardoso Rios
Marcos Cardoso Rios
CSCarlos Adriano Santos Souza
Carlos Adriano Santos Souza
IBIzadora Menezes da Cunha Barros
Izadora Menezes da Cunha Barros
DLDivaldo Pereira de Lyra-Júnior
Divaldo Pereira de Lyra-Júnior
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The clinical activities developed by pharmacists in a hospital environment can improve health outcomes and generate savings for hospitals. However, to determine whether pharmaceutical interventions are cost effective, it is essential to define a method according to which cost-effectiveness is intended to be measured. In addition, the quality of economic assessments and the amount of information present in systematic reviews in the literature make it difficult to analyze the effects of this intervention. Objective: This paper aims to provide an overview of systematic reviews on the pharmacoeconomic impact of the performance of pharmaceutical care in hospitals. Methods: A systematic search of the Cochrane Library databases, PubMed or MEDLINE, LILACS, Scopus, Web of Science, Google Scholar, and Open Thesis will be performed using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The search will involve the use of keywords determined using the Medical Subject Headings database to define the search terms and include the following terms: “pharmacoeconomics,” “pharmaceutical care,” and “hospital.” The study designs to be included will be systematic reviews of good quality. Studies will be included that address pharmacoeconomics; studies that evaluated pharmaceutical care in hospitals; and studies published in Portuguese, English, or Spanish. The primary outcome sought in the systematic reviews will be the cost ratio in monetary units and the outcomes in monetary or natural units. The secondary economic outcomes considered will be determined based on factors associated with the drugs and translated into benefit, efficacy, or utility. Results: It is intended to start this overview in January 2023. Thus far, only previous searches have been carried out to contextualize the theme and build the protocol. Conclusions: This overview will determine the pharmacoeconomic impact of pharmaceutical care interventions in the hospital environment. In addition, this study will point out which clinical outcomes in natural units are impacted by the performance of pharmaceutical care and the strengths and limitations of each approach. It will also identify gaps in the literature and areas for future work. Trial Registration: PROSPERO CRD42019140665; https://tinyurl.com/bddwnz43